-
Mashup Score: 0Generic But Expensive: Why Prices Can Remain High for Off-Patent Drugs - 10 month(s) ago
Brand-name prescription drugs are sold at extremely high prices in the US because patents and other market exclusivities provided by the government allow manufa
Source: papers.ssrn.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 5Generic But Expensive: Why Prices Can Remain High for Off-Patent Drugs by Frazer Tessema, Aaron S. Kesselheim, Michael S. Sinha :: SSRN - 3 year(s) ago
Brand-name prescription drugs are sold at extremely high prices in the US because patents and other market exclusivities provided by the government allow manufa
Source: papers.ssrn.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4Generic but Expensive: Why Prices Can Remain High for Off-Patent Drugs | Hastings Law Journal - 3 year(s) ago
Frazer A. Tessema, Aaron S. Kesselheim, Michael S. Sinha Volume 71, Issue 4, 1019-1052 Brand-name prescription drugs are sold at extremely high prices in the US because patents and other market exclusivities provided by the government allow manufacturers to exclude direct competition. This period of market […]
Categories: Cardiologists, Latest HeadlinesTweet
We wrote about the relationship between #DrugShortages & niche markets (drugs with ≤3 manufacturers) in @HastingsLJ Today, many generic cancer drugs are precariously located in this "Bermuda triangle" - we offer several reforms in #GenericButExpensive: https://t.co/tikKcxVHlw https://t.co/e2xi79HmZu https://t.co/UWpLzDoNG5